Homebiotech

biotech

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026

biotech

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

Jim Cornall - April 30, 2026

biotech

Aragen launches India’s first women-led chemistry synthesis laboratory

Jim Cornall - April 30, 2026

biotech

Vaccine strategy induces broadly neutralising HIV antibodies

Jim Cornall - April 30, 2026

biotech

Health Canada approves first treatment for Duchenne muscular dystrophy

Jim Cornall - October 14, 2025

biotech

Neuroblastoma treatment receives Orphan Drug Designation

Jim Cornall - October 13, 2025

biotech

Base to Base biotech podcast 30: Life sciences in Lithuania

Jim Cornall - October 9, 2025

biotech

Encouraging results from Canavan disease trial

Jim Cornall - October 9, 2025

biotech

Collaboration to address CAR-T cell therapy for brain cancer

Jim Cornall - October 9, 2025

biotech

Precision Cell Systems acquires BennuBio

Jim Cornall - October 9, 2025

biotech

Blood test for chronic fatigue syndrome unveiled

admin - October 8, 2025

biotech

New antibiotic targets IBD

Jim Cornall - October 8, 2025

1...424344...73 Page 43 of 73

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression

Jim Cornall - May 1, 2026 0

This week, our conversations are with Uwe Diegel, CEO of Lifeina, about their cooling technologies, and with Dirk Beher, CEO of FundaMental Pharma, about...

ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma

biotech Jim Cornall - April 30, 2026 0

Aragen launches India’s first women-led chemistry synthesis laboratory

biotech Jim Cornall - April 30, 2026 0

Vaccine strategy induces broadly neutralising HIV antibodies

biotech Jim Cornall - April 30, 2026 0

New target for cancer treatment

biotech Jim Cornall - April 29, 2026 0